Rejected at 7:26 p.m. Mar, 27, 2024 ] by thomas.holmes
Author: samfisch98
Related Note: 1481330882808
Rationale for change

Primary polycythemia which can be caused by polycythemia vera does not increase the plasma volume (see diagnostics/differential). Plasma volume is normal. Also, platelets are not part of the plasma so how could they increase plasma volume.
Source: AMBOSS - https://next.amboss.com/us/article/kT0mI2?q=polycythemia+vera#Z86941b92e2c44caf6d6becf9171d08b2

Rejection reason

FAS1 2023 pg 460 says increased plama volume. Card also has multiple UW tags so I wouldn't change this unless it was asked in a question and the answer was different.

Text Text
Extra
- Due to increased proliferation of platelets


- However can be normal (AMBOSS, June 2024)

Increased plasma volume manifests with:
- Hypertension and increased bleeding (due to engorged vessels)
- Facial plethora (red puffy skin)
- Large retinal veins on fundoscopy and visual disturbances (increased ICP transmitted through optic nerve meninges)
- Headache (stretching of meninges)
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
OME

Additional Resources
Other:
One by one
Empty field
#AK_Step1_v12::#FirstAid::10_Hematology_Oncology::04_Pathology::29_Chronic_Myeloproliferative_Disorders::Polycythemia_Vera #AK_Step1_v12::#OME::04_Organ_Systems::05_Hematology_Oncology::04_Proliferation::02_Myeloproliferation #AK_Step2_v12::#UWorld::COMLEX::28693 !AK_UpdateTags::Step1decks::Zanki-Step-Decks::Zanki-Hematology-&-Oncology::Pathoma-WBC #AK_Step1_v12::^Other::^HighYield::1-HighYield #AK_Step1_v12::#Pathoma::06_WBC::04_Myeloproliferative #AK_Step2_v12::#B&B::07_Hematology_&_Oncology::03_White_Cells::02_Myeloproliferative_Disorders #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step1_v12::#SketchyPath::10_Myeloid_&_Lymphoid::01_Myeloid_Disorders::03_Polycythemia #AK_Step2_v12::Original_decks::Dorian::im::ome::heme/onc::leukemia #AK_Step2_v12::#UWorld::Step::2883 #AK_Step1_v12::#UWorld::Step::8559 #AK_Step1_v12::#FirstAid::10_Hematology_Oncology::04_Pathology::30_Polycythemia #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::10_Plasma_Cell_Dyscrasias_&_Myeloproliferative_Disease::03_Polycythemia_Vera_&_Essential_Thrombocythemia #AK_Step1_v12::#AMBOSS::4ma3fO #AK_Step1_v12::#OME::Clinical::04_Organ_Systems::05_Hematology_Oncology::04_Proliferation::02_Myeloproliferation #AK_Step1_v12::#FirstAid::10_Hematology_Oncology::04_Pathology::30_Polycythemia::Polycythemia_Vera #AK_Step1_v12::^Other::^FA_Updates::FA2018 #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::Pathoma_WBC #AK_Step1_v12::^Systems::HemeOnc::WBC #AK_Step2_v12::#OME::01_Medicine::05_Hematology_Oncology::05_Leukemia #AK_Step2_v12::#AMBOSS::ZF0Zg3 #AK_Step2_v12::#Resources_by_rotation::IM::ome::heme/onc::leukemia #AK_Step1_v12::#B&B::11_Hematology::03_WBC::07_Myeloproliferative_Disorders #AK_Step1_v12::#UWorld::COMLEX::25425 #AK_Step1_v12::^Other::^EXPN::BGedit